Asian Tea & Exports Limited is an established Indian enterprise with over **40 years** of experience in the tea industry. Under the leadership of founder and Managing Director, Mr. Hariram Garg, the company has evolved from a specialized tea trader into a diversified conglomerate engaged in the trading and export of agricultural commodities, industrial goods, and petroleum products. The company is currently executing a strategic pivot toward capital structure optimization and revenue diversification. --- ### **Core Business Segments & Market Presence** The company operates through a multi-commodity trading model, leveraging its historical expertise in tea to expand into high-growth agricultural and industrial sectors. * **Agri-Commodities:** * **Tea:** Procurement, manufacture, and distribution of "made tea." * **Pulses:** Specialized focus on **Yellow Peas** and **Dal**. The company is positioning itself to capture growth in the Indian pulses market, which is projected to grow from **3.6 crore Tons (2024)** to **6 crore Tons by 2033** at a **CAGR of 5.38%**. * **Grains:** Trading of rice and wheat. * **Industrial & Other Goods:** Trading of fibre boards, elevators, and cotton yarn. * **Petroleum & Energy:** Effective **April 12, 2024**, the company entered a partnership under the name **'National Petroleum Corporation'** based in New Delhi, focusing on trading and distributorship of petroleum products. * **Infrastructure:** Operates a primary factory and warehouse at **Budge Budge Trunk Road, West Bengal**, with its registered office in **Kolkata**. --- ### **Corporate Structure & Strategic Holdings** The group maintains a robust network of subsidiaries and associates to manage its diverse interests in plantations and trading. | Category | Entity Name | Ownership/Status | | :--- | :--- | :--- | | **Subsidiary** | **Herbby Tea Plantations Pvt. Ltd.** | **100%** (Acquired 2023) | | **Subsidiary** | **Greenol Laboratories Pvt. Ltd.** | Wholly Owned/Controlled | | **Subsidiary** | **Sarita Nupur Vyapar Pvt. Ltd.** | Wholly Owned/Controlled | | **Associate** | **Kesavatsapur Tea Co. Pvt. Ltd.** | Active Associate | | **Associate** | **Asian Tea Co. Pvt. Ltd.** | Active Associate | | **Associate** | **Hurdeodass Co. Pvt. Ltd.** | Active Associate | *Note: The group recently streamlined its portfolio; **HRG Healthcare Private Limited** and **Indong Tea Company Limited** ceased to be associates in FY24 and FY23, respectively.* --- ### **Financial Position & Capital Management** The company has focused on aggressive debt reduction and capital raising to strengthen its balance sheet. **Debt Profile (Consolidated):** | Particulars (Rs. in '000s) | 31st March 2024 | 31st March 2023 | 31st March 2022 | | :--- | :--- | :--- | :--- | | **Total Debt** | **2,41,181** | **2,55,044** | **3,74,013** | **Key Financial Metrics (FY 2024-25):** * **Total Revenue:** **Rs. 1,595.65 lacs** * **Net Loss:** **Rs. 10.24 lacs** * **Associate Profit Contribution:** **Rs. 42.32 lacs** * **Total Assets (Subsidiaries):** **Rs. 2,790.70 lacs** **Capital Raising Activities:** In **February 2025**, the company successfully allotted **49,41,800** fully paid-up equity shares at **Rs. 19** per share (including a **Rs. 9** premium), raising **Rs. 9.39 Crore**. While the original target was **Rs. 17.10 Crore** via **90,00,000** shares, the proceeds were utilized to fund **Working Capital** and **General Corporate Purposes**. --- ### **Governance & Leadership Continuity** The company is managed by a mix of veteran promoters and independent oversight. * **Executive Leadership:** Mr. Hariram Garg was re-appointed as **Chairman & Managing Director** until **September 28, 2028**, ensuring long-term strategic stability. * **Key Appointments:** * **Mr. Priyarup Mukherjee:** Company Secretary & Compliance Officer (Effective **Oct 2025**). * **Mr. Rajnish Kumar Kansal:** Independent Director (Effective **June 2024**). * **Mr. Manish Jajodia:** Independent Director (Term: **2023–2028**). * **Promoter Realignment:** In **March 2026**, an internal restructuring occurred where **Greenex Chemicals Private Limited** merged into **IBM Finance and Investment Private Limited**, resulting in an inter-se transfer of **28,35,982 shares (11.37%)** within the promoter group. --- ### **Risk Profile & Audit Observations** Investors should note specific financial and regulatory nuances currently affecting the company. **1. Asset Valuation & Receivables:** * **Unprovisioned Debtors:** As of **February 2026**, the company carries **Rs. 158.35 lacs** in debtors outstanding for over **3 years**. Management has not made provisions, expecting full recovery. * **Investment Diminution:** The company holds **7,93,557 shares** in **Doyapore Tea Industries Pvt. Ltd.** at a cost of **Rs. 2.55 crore**. Despite a decline in audited value to **Rs. 2.35 crore**, management considers the **Rs. 20.04 lakh** diminution as "temporary" and has not recognized a loss. **2. Regulatory & Listing Status:** * **Trading Approvals:** While **49,41,800** new shares were allotted in **2025**, trading approval from the **BSE** is still pending. Furthermore, the **Calcutta Stock Exchange (CSE)** has not yet responded to applications for in-principle approval. * **GST Inspection:** A regulatory inspection was conducted by the **Bureau of Investigation (South Bengal)** at the registered office in **November 2025** under the West Bengal GST Act. **3. Operational Risks:** * **Agricultural Volatility:** Exposure to weather patterns and remote logistics in tea-growing regions. * **Currency Exposure:** The company manages risks in **USD, EUR, and GBP** through a policy of hedging highly probable forecast cash flows. * **Market Dynamics:** Fluctuating tea prices and rising employee benefit costs remain primary pressures on margins. --- ### **Strategic Outlook** Asian Tea & Exports Limited is transitioning from a traditional tea exporter to a diversified commodity player. By expanding into the **petroleum sector** and targeting the high-growth **pulses market**, the company aims to mitigate the cyclicality of the tea industry. The recent capital infusion of **Rs. 9.39 crore** and the consolidation of promoter holdings suggest a focus on stabilizing the balance sheet to support these new revenue streams. Auditors have confirmed the company’s **solvency**, noting no material uncertainty regarding its ability to meet liabilities due within the next **12 months**.